Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results

NeuBase Therapeutics, Inc. (OHRP) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/11/2023 ARS Form ARS - Annual Report to Security Holders:
08/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/11/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/11/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/03/2023 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs...
08/01/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
07/31/2023 8-K Quarterly results
07/28/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
07/07/2023 D Form D - Notice of Exempt Offering of Securities:
06/30/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Series A Common Stock Purchase Warrant",
"Form of Series B Common Stock Purchase Warrant",
"Form of Pre-Funded Common Stock Purchase Warrant (Registered Direct Offering)",
"Form of Pre-Funded Common Stock Purchase Warrant (PIPE Private Placement)",
"Form of Placement Agent Common Stock Purchase Warrant",
"Opinion of Paul Hastings LLP",
"Securities Purchase Agreement, (Registered Direct Offering)",
"Securities Purchase Agreement, (PIPE Private Placement)",
"Registration Rights Agreement",
"NeuBase Announces $5 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules"
06/30/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/30/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 8-K Quarterly results
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/24/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/14/2023 10-Q Quarterly Report for the period ended December 31, 2022
01/27/2023 SC 13G/A Kershner Trading Americas,LLC reports a 4.5% stake in NeuBase Therapeutics, Inc.
12/29/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/29/2022 8-K Quarterly results
12/21/2022 8-K Quarterly results
12/21/2022 10-K Annual Report for the period ended September 30, 2022
10/24/2022 8-K Quarterly results
10/14/2022 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
Docs: "NeuBase Therapeutics Announces Strategic Restructuring Focused on Advancing Its Platform in Gene Editing"
10/03/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/12/2022 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "Outside Director Compensation Policy"
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/11/2022 8-K Quarterly results
07/22/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy